Leerink, Cantor Fitzgerald and Oppenheimer acted as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AQST:
- Aquestive Therapeutics Secures $75M Funding for Anaphylm
- Aquestive Therapeutics announces $75M strategic funding agreement with RTW
- Aquestive Therapeutics Reports Q2 2025 Financial Results
- AQST Earnings this Week: How Will it Perform?
- Aquestive Therapeutics Faces Potential Risks with ‘5050Item’: What Investors Need to Know